Reste-t-il une place pour les digitaliques dans le traitement de l’insuffisance cardiaque ?
Author:
- 7 January 2026
- journal article
- Published by Elsevier in Bulletin de l'Académie Nationale de Médecine
- Vol. 210 (2) , 102-105
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Digitoxin in Patients with Heart Failure and Reduced Ejection FractionNew England Journal of Medicine, 2025
- Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of LifeJAMA, 2020
- Digoxin and Mortality in Patients With Atrial FibrillationJACC, 2018
- Temporal Trends of Digoxin Use in Patients Hospitalized With Heart FailureJACC: Heart Failure, 2016
- Digoxin-associated mortality: a systematic review and meta-analysis of the literatureEuropean Heart Journal, 2015
- Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysisThe Lancet, 2014
- Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trialEuropean Heart Journal, 2005
- Association of Serum Digoxin Concentration and Outcomes in Patients With Heart FailureJAMA, 2003
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Digoxin for chronic heart failure: A review of the randomized controlled trials with special attention to the PROVED and RADIANCE trialsProgress in Cardiovascular Diseases, 1994